Circulating T-regulatory cells in PNET: A prospective study

Pediatric Blood and Cancer

Volumn 61, Issue 2, 2014, Pages 228-232

  Tilak, T V S V G K ^a   Sharawat, Surender ^a   Gupta, Ritu ^a   Agarwala, Sandeep ^a   Vishnubhatla, Sreenivas ^a   Bakhshi, Sameer ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Ewing sarcoma; PNET; T regulatory cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FEVER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; NEUROECTODERM TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL NEUROECTODERM TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; RELAPSE; SCHOOL CHILD; UPREGULATION;

EID: 84890875022     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24734     Document Type: Article

References (18)

1. Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell 2008; 133:775-787.
2. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-949.
3. Bates GJ, Fox SB, Han C, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 2006; 24:5373-5380.
4. Sasada T, Kimura M, Yoshida Y, et al. CD4+ CD25+ regulatory T cells in patients with gastrointestinal malignancies: Possible involvement of regulatory T cells in disease progression. Cancer 2003; 98:1089-1099.
5. Yamamoto T, Yanagimoto H, Satoi S, et al. Circulating CD4+ CD25+ regulatory T cells in patients with pancreatic cancer. Pancreas 2012; 41:409-415.
6. Gupta R, Ganeshan P, Hakim M, et al. Significantly reduced regulatory T cell population in patients with untreated multiple myeloma. Leuk Res 2011; 35:874-878.
7. Correale P, Rotundo MS, Del Vecchio MT, et al. Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J Immunother 2010; 33:435-441.
8. Leffers N, Gooden MJM, de Jong RA, et al. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother 2009; 58:449-459.
9. Brinkrolf P, Landmeier S, Altvater B, et al. A high proportion of bone marrow T cells with regulatory phenotype (CD4+ CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease. Int J Cancer 2009; 125:879-886.
10. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348:694-701.
11. Strauss L, Bergmann C, Szczepanski M, et al. A unique subset of CD4+ CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res 2007; 13:4345-4354.
12. Strauss L, Bergmann C, Gooding W, et al. The frequency and suppressor function of CD4+ CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2007; 13:6301-6311.
13. Mougiakakos D, Choudhury A, Lladser A, et al. Regulatory T cells in cancer. Adv Cancer Res 2010; 107:57-117.
14. Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9:606-612.
15. Noonan K, Marchionni L, Anderson J, et al. A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma. Blood 2010; 116:3554-3563.
16. Hodge G, Scott J, Osborn M, et al. Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patients. Cytokine 2011; 53:286-288.
17. Zhu LY, Chi LJ, Wang X, et al. Reduced circulating CD4+ CD25+ cell populations in haemorrhagic fever with renal syndrome. Clin Exp Immunol 2009; 156:88-96.
18. Le DT, Jaffee EM. Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: A current perspective. Cancer Res 2012; 72:3439-3444.